Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
Apolipoprotein E4 confers a dose-related risk for developing Alzheimer's disease.
There is experimental evidence which permits estimation of the size of the risk:
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.